Auxly Cannabis Group Inc. (XLY.TO)
CAD 0.09
(0.0%)
CAD 0.09
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 40.28 Million CAD | -38.49% |
| 2022 | 65.48 Million CAD | 12.47% |
| 2021 | 58.22 Million CAD | -0.02% |
| 2020 | 58.23 Million CAD | -1.06% |
| 2019 | 58.86 Million CAD | 16.71% |
| 2018 | 50.43 Million CAD | 180.79% |
| 2017 | 17.96 Million CAD | 3149.13% |
| 2016 | 552.83 Thousand CAD | 248.65% |
| 2015 | 158.56 Thousand CAD | -13.47% |
| 2014 | 183.24 Thousand CAD | -24.71% |
| 2013 | 243.39 Thousand CAD | 28.48% |
| 2012 | 189.43 Thousand CAD | 57.39% |
| 2011 | 120.36 Thousand CAD | -49.19% |
| 2010 | 236.87 Thousand CAD | 9.44% |
| 2009 | 216.44 Thousand CAD | -19.04% |
| 2008 | 267.34 Thousand CAD | 27.19% |
| 2007 | 210.19 Thousand CAD | -92.79% |
| 2006 | 2.91 Million CAD | 0.83% |
| 2005 | 2.89 Million CAD | 159.96% |
| 2004 | 1.11 Million CAD | 104.29% |
| 2003 | 544.53 Thousand CAD | 152.97% |
| 2002 | 215.25 Thousand CAD | -37.93% |
| 2001 | 346.77 Thousand CAD | -6.52% |
| 2000 | 370.97 Thousand CAD | 38.34% |
| 1999 | 268.16 Thousand CAD | 30.22% |
| 1998 | 205.92 Thousand CAD | 1080.02% |
| 1997 | 17.45 Thousand CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 10.54 Million CAD | 6.84% |
| 2024 Q2 | 10.01 Million CAD | -5.08% |
| 2023 Q3 | 12.54 Million CAD | 15.47% |
| 2023 FY | 40.28 Million CAD | -38.49% |
| 2023 Q4 | 9.87 Million CAD | -21.27% |
| 2023 Q1 | 12.24 Million CAD | -3.86% |
| 2023 Q2 | 10.86 Million CAD | -11.3% |
| 2022 FY | 65.48 Million CAD | 12.47% |
| 2022 Q4 | 12.73 Million CAD | -18.15% |
| 2022 Q3 | 15.55 Million CAD | -21.23% |
| 2022 Q1 | 17.44 Million CAD | -6.05% |
| 2022 Q2 | 19.75 Million CAD | 13.24% |
| 2021 Q3 | 13.78 Million CAD | -3.2% |
| 2021 Q1 | 11.92 Million CAD | -1.45% |
| 2021 Q4 | 18.56 Million CAD | 34.68% |
| 2021 FY | 58.22 Million CAD | -0.02% |
| 2021 Q2 | 14.24 Million CAD | 19.45% |
| 2020 Q1 | 16.39 Million CAD | 2.6% |
| 2020 FY | 58.23 Million CAD | -1.06% |
| 2020 Q2 | 16.07 Million CAD | -1.92% |
| 2020 Q4 | 12.09 Million CAD | -11.53% |
| 2020 Q3 | 13.67 Million CAD | -14.95% |
| 2019 Q1 | 12 Million CAD | -24.05% |
| 2019 FY | 58.86 Million CAD | 16.71% |
| 2019 Q2 | 12.76 Million CAD | 6.3% |
| 2019 Q3 | 18.12 Million CAD | 41.99% |
| 2019 Q4 | 15.97 Million CAD | -11.84% |
| 2018 Q1 | 7.8 Million CAD | -22.98% |
| 2018 Q4 | 15.8 Million CAD | -2.44% |
| 2018 FY | 50.43 Million CAD | 180.79% |
| 2018 Q2 | 10.61 Million CAD | 36.01% |
| 2018 Q3 | 16.2 Million CAD | 52.62% |
| 2017 FY | 17.96 Million CAD | 3149.13% |
| 2017 Q2 | 1.54 Million CAD | 4.68% |
| 2017 Q3 | 4.78 Million CAD | 209.66% |
| 2017 Q1 | 1.47 Million CAD | 242.6% |
| 2017 Q4 | 10.13 Million CAD | 111.88% |
| 2016 Q2 | 46.44 Thousand CAD | 12.1% |
| 2016 Q4 | 430.73 Thousand CAD | 710.81% |
| 2016 Q1 | 41.43 Thousand CAD | 4.62% |
| 2016 FY | 552.83 Thousand CAD | 248.65% |
| 2016 Q3 | 53.12 Thousand CAD | 14.38% |
| 2015 Q3 | 60.55 Thousand CAD | 26.43% |
| 2015 FY | 158.56 Thousand CAD | -13.47% |
| 2015 Q1 | 45.05 Thousand CAD | 63.56% |
| 2015 Q2 | 47.89 Thousand CAD | 6.31% |
| 2015 Q4 | 39.6 Thousand CAD | -34.6% |
| 2014 Q4 | 27.54 Thousand CAD | -51.03% |
| 2014 FY | 183.24 Thousand CAD | -24.71% |
| 2014 Q2 | 67.29 Thousand CAD | 22.72% |
| 2014 Q1 | 54.83 Thousand CAD | -0.42% |
| 2014 Q3 | 56.24 Thousand CAD | -16.43% |
| 2013 Q4 | 55.06 Thousand CAD | -23.34% |
| 2013 FY | 243.39 Thousand CAD | 28.48% |
| 2013 Q3 | 71.83 Thousand CAD | -2.53% |
| 2013 Q2 | 73.69 Thousand CAD | 12.55% |
| 2013 Q1 | 65.47 Thousand CAD | -24.45% |
| 2012 Q2 | 35.09 Thousand CAD | 16.62% |
| 2012 Q3 | 37.59 Thousand CAD | 7.12% |
| 2012 Q4 | 86.66 Thousand CAD | 130.56% |
| 2012 FY | 189.43 Thousand CAD | 57.39% |
| 2012 Q1 | 30.09 Thousand CAD | 1.87% |
| 2011 Q4 | 29.53 Thousand CAD | -2.29% |
| 2011 Q3 | 30.23 Thousand CAD | -0.12% |
| 2011 Q2 | 30.26 Thousand CAD | -53.23% |
| 2011 Q1 | 64.7 Thousand CAD | -11.42% |
| 2011 FY | 120.36 Thousand CAD | -49.19% |
| 2010 Q3 | 57.44 Thousand CAD | 14.61% |
| 2010 FY | 236.87 Thousand CAD | 9.44% |
| 2010 Q4 | 73.04 Thousand CAD | 27.17% |
| 2010 Q2 | 50.12 Thousand CAD | -10.92% |
| 2010 Q1 | 56.26 Thousand CAD | 18.7% |
| 2009 Q2 | 76.16 Thousand CAD | 68.72% |
| 2009 Q4 | 47.4 Thousand CAD | -0.7% |
| 2009 Q3 | 47.73 Thousand CAD | -37.33% |
| 2009 FY | 216.44 Thousand CAD | -19.04% |
| 2009 Q1 | 45.14 Thousand CAD | -54.18% |
| 2008 FY | 267.34 Thousand CAD | 27.19% |
| 2008 Q4 | 98.52 Thousand CAD | 125.43% |
| 2008 Q1 | 67.89 Thousand CAD | 104.74% |
| 2008 Q2 | 57.21 Thousand CAD | -15.74% |
| 2008 Q3 | 43.7 Thousand CAD | -23.61% |
| 2007 FY | 210.19 Thousand CAD | -92.79% |
| 2007 Q4 | -1.43 Million CAD | -373.7% |
| 2007 Q3 | 523.55 Thousand CAD | -13.26% |
| 2007 Q2 | 603.58 Thousand CAD | 16.96% |
| 2007 Q1 | 516.04 Thousand CAD | -16.49% |
| 2006 FY | 2.91 Million CAD | 0.83% |
| 2006 Q1 | 646.2 Thousand CAD | -52.84% |
| 2006 Q4 | 617.95 Thousand CAD | -37.35% |
| 2006 Q2 | 665.34 Thousand CAD | 2.96% |
| 2006 Q3 | 986.43 Thousand CAD | 48.26% |
| 2005 Q4 | 1.37 Million CAD | 126.94% |
| 2005 FY | 2.89 Million CAD | 159.96% |
| 2005 Q1 | 437 Thousand CAD | 4.19% |
| 2005 Q3 | 603.79 Thousand CAD | 25.57% |
| 2005 Q2 | 480.83 Thousand CAD | 10.03% |
| 2004 Q3 | 241.04 Thousand CAD | 26.85% |
| 2004 FY | 1.11 Million CAD | 104.29% |
| 2004 Q1 | 237.51 Thousand CAD | 704.27% |
| 2004 Q2 | 190.01 Thousand CAD | -20.0% |
| 2004 Q4 | 419.43 Thousand CAD | 74.01% |
| 2003 Q4 | -39.3 Thousand CAD | -119.84% |
| 2003 Q3 | 198.15 Thousand CAD | -25.59% |
| 2003 Q2 | 266.31 Thousand CAD | 123.09% |
| 2003 Q1 | 119.37 Thousand CAD | 46.57% |
| 2003 FY | 544.53 Thousand CAD | 152.97% |
| 2002 FY | 215.25 Thousand CAD | -37.93% |
| 2002 Q3 | 420.8 Thousand CAD | 461.56% |
| 2002 Q4 | 81.44 Thousand CAD | -80.65% |
| 2002 Q1 | 23.46 Thousand CAD | -86.26% |
| 2002 Q2 | 74.93 Thousand CAD | 219.4% |
| 2001 Q1 | 93.96 Thousand CAD | -33.19% |
| 2001 Q3 | 32.91 Thousand CAD | -33.01% |
| 2001 Q2 | 49.13 Thousand CAD | -47.71% |
| 2001 Q4 | 170.75 Thousand CAD | 418.74% |
| 2001 FY | 346.77 Thousand CAD | -6.52% |
| 2000 Q2 | 36.83 Thousand CAD | -30.2% |
| 2000 Q1 | 52.76 Thousand CAD | -66.74% |
| 2000 FY | 370.97 Thousand CAD | 38.34% |
| 2000 Q3 | 140.74 Thousand CAD | 282.13% |
| 2000 Q4 | 140.64 Thousand CAD | -0.07% |
| 1999 FY | 268.16 Thousand CAD | 30.22% |
| 1999 Q1 | 14.77 Thousand CAD | 0.0% |
| 1999 Q4 | 158.66 Thousand CAD | 422.0% |
| 1999 Q2 | 64.33 Thousand CAD | 335.51% |
| 1999 Q3 | 30.39 Thousand CAD | -52.75% |
| 1998 Q1 | 22.79 Thousand CAD | -8.3% |
| 1998 Q2 | 74.91 Thousand CAD | 228.6% |
| 1998 FY | 205.92 Thousand CAD | 1080.02% |
| 1997 FY | 17.45 Thousand CAD | 0.0% |
| 1997 Q4 | 24.86 Thousand CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Aurora Cannabis Inc. | 158.53 Million CAD | 74.592% |
| Avicanna Inc. | 14.59 Million CAD | -176.061% |
| Avant Brands Inc. | 5.65 Million CAD | -611.822% |
| Cardiol Therapeutics Inc. | 29.53 Million CAD | -36.377% |
| Crescita Therapeutics Inc. | 12.32 Million CAD | -226.964% |
| Knight Therapeutics Inc. | 155.54 Million CAD | 74.102% |
| MediPharm Labs Corp. | 23.08 Million CAD | -74.509% |
| OrganiGram Holdings Inc. | 277.81 Million CAD | 85.5% |
| Canopy Growth Corporation | 308.61 Million CAD | 86.947% |
| Willow Biosciences Inc. | 7.55 Million CAD | -433.254% |